Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Subsequent monthly refills arrive with the same level of support for $499 (injection) or $399 (oral)
Tirzepatide-based evidence from the SURPASS (Researching Tirzepatide in Patients with Type 2 Diabetes for Glycemic Control and Weight Management) trials (SURPASS-1 NCT03954834 and SURPASS-5 NCT04039503) demonstrated dose-dependent, significant weight loss over 40 weeks compared with placebo, along with reductions in BMI and waist circumference [62, 63]
Turner, N
That same study found that over half the test subjects showed some kind of adverse reaction, such as nausea, constipation, abdominal pain, or diarrhea, though in most cases those side effects were classified as mild to moderate
US$ 27.71
US$ 21.50
US$ 26.08
US$ 23.86
US$ 23.32
US$ 25.72
US$ 22.77
US$ 29.92
US$ 29.54
US$ 29.60
